Stockreport

Qualigen Therapeutics, Inc. Announces management changes.

Qualigen Therapeutics, Inc.  (QLGN) 
PDF CARLSBAD, Calif., Sept. 26, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) announced on September 23, 2024, Mr. Michael Poirier, n [Read more]